Assessment of Tele-expertise for Second Medical Opinion on Pathological Diagnosis

NCT ID: NCT02374697

Last Updated: 2015-12-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

470 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-09-30

Study Completion Date

2015-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether digitalizing pathological slides and let it accessible on a server for a second medical opinion (tele-expertise) would reduce the time to diagnosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anatomical Pathological Condition

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Second opinion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Before tele-expertise

Usual second opinion with pathological slides sent by mailing

No interventions assigned to this group

During Tele-expertise

Second opinion with tele-expertise

During tele-expertise

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

During tele-expertise

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients in need for a second medical opinion on a pathological sample

Exclusion Criteria

* None
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Agence Regionale de Sante d'Ile de France

OTHER_GOV

Sponsor Role collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Catherine Guettier, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Hôpital Bicêtre. Assistance Publique - Hôpitaux de Paris

Isabelle Durand-Zaleski, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

DRCD URC Eco. Assistance Publique - Hôpitaux de Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Saint Antoine

Paris, Paris, France

Site Status

Centre de Pathologie- Bièvres

Bièvres, , France

Site Status

Hôpital Henri Mondor

Créteil, , France

Site Status

Centre Hospitalier Simone Veil

Eaubonne, , France

Site Status

Hôpital Bicêtre

Le Kremlin-Bicêtre, , France

Site Status

Hôpital Bichat

Paris, , France

Site Status

Hôpital Cochin

Paris, , France

Site Status

Hôpital Saint Louis

Paris, , France

Site Status

Centre Hospitalier René Dubos

Pontoise, , France

Site Status

Hôpital Paul Brousse

Villejuif, , France

Site Status

Centre Hospitalier de Villeneuve Saint Georges

Villeneuve-Saint-Georges, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Kidholm K, Ekeland AG, Jensen LK, Rasmussen J, Pedersen CD, Bowes A, Flottorp SA, Bech M. A model for assessment of telemedicine applications: mast. Int J Technol Assess Health Care. 2012 Jan;28(1):44-51. doi: 10.1017/S0266462311000638.

Reference Type BACKGROUND
PMID: 22617736 (View on PubMed)

Charrier N, Zarca K, Durand-Zaleski I, Calinaud C; ARS Ile de France telemedicine group. Efficacy and cost effectiveness of telemedicine for improving access to care in the Paris region: study protocols for eight trials. BMC Health Serv Res. 2016 Feb 8;16:45. doi: 10.1186/s12913-016-1281-1.

Reference Type DERIVED
PMID: 26857558 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TLM-Pathology Expertise

Identifier Type: -

Identifier Source: org_study_id